elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33696974-6E2C619E-A507-4EC8-81EC-9017F6E8712F
Q33696974-6E2C619E-A507-4EC8-81EC-9017F6E8712F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33696974-6E2C619E-A507-4EC8-81EC-9017F6E8712F
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease.
P275
Q33696974-6E2C619E-A507-4EC8-81EC-9017F6E8712F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33696974-6E2C619E-A507-4EC8-81EC-9017F6E8712F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39e47b4a67045f63c011f84d2b07293032a01de0
4f6d548d8dd6a2d8db2396ef2f137d5fa21eceb6
99b1e90c7766397ca96cd7cca7644d10467b42fa
a554c8355a1abf8acf3201ccc8ab8c285a324b2a
c09913c5dda05662c9c9e5346ebdcd65ec4347ff
d2fe3fc95796e5059f8ae8a3ff4353be7662e58f
P275
Creative Commons Attribution 4.0 International